Results 1 to 10 of about 46,126 (242)

Surface-Modified Polymeric Nanoparticles for Glioblastoma Therapy: A Review on Targeting Strategies and Delivery of Repurposed Drugs and Off-Label Non-Alkylating Agents [PDF]

open access: yesPharmaceutics
Glioblastoma (GBM) remains the most aggressive primary brain tumor, with poor outcomes under the current standard-of-care with temozolomide (TMZ). Therapeutic failure is multifactorial, mainly driven by TMZ resistance mediated by DNA repair enzymes (MGMT)
Daniela Maria Sousa   +3 more
doaj   +2 more sources

Loss of p21 does not protect against premature ovarian insufficiency caused by alkylating agents [PDF]

open access: yesFrontiers in Endocrinology
BackgroundRecent studies have focused on investigating the role of cellular senescence in ovarian aging. Targeting cellular senescence has been proposed as a potential strategy to improve ovarian aging.
Xiaohui Lu   +8 more
doaj   +2 more sources

Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents [PDF]

open access: yesNeoplasia: An International Journal for Oncology Research
The ADP-ribosyl hydrolases PARG and ARH3 counteract PARP enzymatic activity by removing ADP-ribosylation. PARG and ARH3 activities have a synthetic lethal effect; however, the specific molecular mechanisms underlying this response remain unknown.
Rocco Caggiano   +12 more
doaj   +2 more sources

In Situ Evaluation of the GSH Depletion Ability of Various Alkylating Agents and the Protective Effect of Several Active Thiol Compounds Based on High-Content Cell Analysis [PDF]

open access: yesToxics
The depletion degree of reduced glutathione is a critical indicator for assessing the toxicity of alkylating agents. In the present research, we have developed a novel method to evaluate the glutathione (GSH) depletion induced by a series of alkylating ...
Jing Guo   +7 more
doaj   +2 more sources

Non‐alkylating agents‐induced gonadotoxicity in pre‐pubertal males: Insights on the clinical and pre‐clinical front [PDF]

open access: yesClinical and Translational Science
Whilst chemotherapy regimens have proven to be more successful for pediatric cancer patients over the years, their influence on long‐term side effects is relatively poorly understood.
Sruthi Sriram   +4 more
doaj   +2 more sources

Novel Pathways of Oxidative and Nitrosative Inactivation of the Human MGMT Protein in Colon Cancer and Glioblastoma Cells: Increased Efficacy of Alkylating Agents In Vitro and In Vivo [PDF]

open access: yesDiseases
Background: O6-Methylguanine-DNA methyltransferase (MGMT) is a unique antimutagenic DNA repair protein that plays a crucial role in conferring resistance to various alkylating agents in brain tumor therapy.
Debasish Basak   +3 more
doaj   +2 more sources

Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer [PDF]

open access: yesFrontiers in Oncology, 2022
Exposure to alkylating agents and radiation may cause damage and apoptosis in cancer cells. Meanwhile, this exposure involves resistance and leads to metabolic reprogramming to benefit cancer cells.
Yu-Chan Chang   +10 more
doaj   +2 more sources

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy [PDF]

open access: yesBiomedicines, 2019
The alkylating agent temozolomide (TMZ) together with maximal safe bulk resection and focal radiotherapy comprises the standard treatment for glioblastoma (GB), a particularly aggressive and lethal primary brain tumor.
Hannah Strobel   +7 more
doaj   +2 more sources

MPTAC links alkylation damage signaling to sterol biosynthesis

open access: yesRedox Biology, 2022
Overproduction of reactive oxygen species (ROS) drives inflammation and mutagenesis. However, the role of the DNA damage response in immune responses remains largely unknown.
Tamaki Suganuma, Jerry L. Workman
doaj   +1 more source

Pseudomonas putida AlkA and AlkB proteins comprise different defense systems for the repair of alkylation damage to DNA - in vivo, in vitro, and in silico studies. [PDF]

open access: yesPLoS ONE, 2013
Alkylating agents introduce cytotoxic and/or mutagenic lesions to DNA bases leading to induction of adaptive (Ada) response, a mechanism protecting cells against deleterious effects of environmental chemicals.
Damian Mielecki   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy